Basics Krystal Biotech, Inc. Krystal Biotech Inc is a biopharmaceutical company. It uses gene therapy treatments for patients suffering from rare debilitating disorders. IPO Date: September 20, 2017 Sector: Healthcare Industry: Biotech Market Cap: $6.79B Activated in VL: True Average Daily Range Avg Daily Range: $1.85 | 2.60% Avg Daily Range (30 D): $2.74 | 1.35% Avg Daily Range (90 D): $3.00 | 1.76% Institutional Daily Volume Avg Daily Volume: .16M Avg Daily Volume (30 D): .23M Avg Daily Volume (90 D): .26M Trade Size Avg Trade Size (Sh.): 43 Avg Trade Size (Sh.) (30 D): 30 Avg Trade Size (Sh.) (90 D): 32 Institutional Trades Total Inst.Trades: 2,171 Avg Inst. Trade: $3.92M Avg Inst. Trade (30 D): $6.08M Avg Inst. Trade (90 D): $5.54M Avg Inst. Trade Volume: .03M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $4.96M Avg Closing Trade (30 D): $8.17M Avg Closing Trade (90 D): $7.67M Avg Closing Volume: 41K     News Dec 4, 2025 @ 12:12 AM Acadia Stock Up 59% in a Year — Is a $51 Mi... Source: Jonathan Ponciano Dec 4, 2025 @ 12:02 AM Soleno Turns First Profit on $66 Million in Revenu... Source: Jonathan Ponciano Nov 26, 2025 @ 1:00 PM Krystal Biotech to Present at 8th Annual Evercore ... Source: Stéphane Paquette Sep 15, 2025 @ 12:00 PM Krystal Biotech Announces FDA Approval of Updated ... Source: Krystal Biotech Aug 8, 2025 @ 4:14 AM Quoin (QNRX) Q2 Loss Beats Estimates Source: Na Financials   TTM Q3 2025 Q2 2025 Basic EPS $2.74 $1.33 Diluted EPS $2.66 $1.29 Revenue $ $ 97.8M $ 96.04M Gross Profit $ $ $ Net Income / Loss $ $ 79.37M $ 38.33M Operating Income / Loss $ $ 41.37M $ 39.31M Cost of Revenue $ $ $ Net Cash Flow $ $ 38.78M $ 45.06M PE Ratio